CSIMarket
 


Nutriband Inc   (NTRB)
Other Ticker:  
 

Cumulative Nutriband Inc 's Total Debt to Equity for Trailing Twelve Months Period

NTRB's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

NTRB Total Debt to Equity for Trailing Twelve Months Period

(Oct 31 2022)
III. Quarter
(Jul 31 2022)
I. Quarter
(Apr 30 2022)
I. Quarter
(Oct 31 2021)
III. Quarter
(Jul 31 2021)
II. Quarter
Y / Y Equity Growth 33.02 % 32.74 % 55.8 % 97.39 % 464.23 %
Y / Y Total Debt Growth -42.91 % -40.9 % -47.15 % -55.77 % 64.75 %
Total Debt to Equity for Trailing Twelve Months Period 0.01 0.01 0.02 0.02 0.03
Total Ranking # 137 # 335 # 452 # # 544
Seq. Equity Growth -6.44 % -6.12 % -22.62 % 95.72 % -6.64 %
Seq. Total Debt Growth -4.89 % -4.39 % 17.5 % -46.57 % -1.54 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to repayements of liabilities of -4.89% Nutriband Inc has not changed Total Debt to Equity for Trailing Twelve Months Period in the III. Quarter to 0.01, below company's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 6 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Nutriband Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has improved so far to 137, from total ranking in previous quarter at 335.

What is Debt to Equity Ratio?
NTRB Charts and Quotes
Total Debt to Equity NTRB in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 7
Sector # 34
S&P 500 # 137


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.13 0.04 0
(Jul 31 2020)   (Oct 31 2022)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Oct 31 2022, within Biotechnology & Pharmaceuticals Industry Total Debt to Equity for Trailing Twelve Months Period
Singular Genomics Systems Inc   0.03 
C4 Therapeutics Inc   0.03 
Gritstone Bio Inc   0.03 
Myriad Genetics Inc   0.03 
Century Therapeutics inc   0.03 
Biontech Se  0.03 
Windtree Therapeutics Inc  0.02 
Ainos Inc   0.02 
Casi Pharmaceuticals inc   0.02 
Pulse biosciences inc   0.02 
Orion Energy Systems Inc   0.02 
Ocugen Inc   0.02 
Hillevax Inc   0.02 
Nutriband Inc   0.01 
Polarityte Inc   0.01 
Miromatrix Medical Inc   0.01 
Oncocyte Corporation  0.01 
Precipio inc   0.01 
Scientific Industries Inc  0.01 
Recursion Pharmaceuticals Inc   0.01 
Inhibikase Therapeutics Inc   0.01 
Applied Uv Inc   0.01 
Vicarious Surgical Inc   0.01 
Kiromic Biopharma Inc 0.00 
Cellectis S a 0.00 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

INVZ's Profile

Stock Price

INVZ's Financials

Business Description

Fundamentals

Charts & Quotes

INVZ's News

Suppliers

INVZ's Competitors

Customers & Markets

Economic Indicators

INVZ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071